Clinical Trials Browser

Phase 2 × OTHER × Leukemia, B-Cell × Clear all

NCT07624799 2026-06-03

PACIFIC

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03766763 2025-11-26

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT06812715 2025-08-06

PIPOZA

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04515238 2025-06-10

CLL2-BZAG

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04883749 2025-06-08

CLL-Frail

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03804372 2025-02-27

CLL1818

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03787264 2024-12-30

CLL2-BAAG

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04605666 2024-08-20

CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT01597219 2024-05-03

UK-Haplo

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05082519 2023-10-26

IDEAL2

Phase 2 Recruiting

LymphoidOtherOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Obesity, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

NCT03899337 2023-01-09

STELLAR

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03852407 2022-10-12

HLA

Phase 2 Recruiting

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, B-Cell, Hematologic Neoplasms

NCT03068416 2021-10-20

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02689141 2020-06-11

Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03598179 2019-08-07

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Phase 2 Terminated

3 enrolled 6 charts

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01279252 2019-01-25

CLEAR

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01446900 2018-01-31

R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00201721 2017-02-08

Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00751296 2016-06-16

Rev-CLL

Phase 2 Terminated

27 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01119794 2015-08-26

Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab

Phase 2 Terminated

10 enrolled 7 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00230282 2014-10-06

Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia

Phase 2 Completed

25 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01127542 2011-12-05

RESPeCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00558181 2010-02-23

LT-CLL-001

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00292760 2009-12-16

A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell